The present pilot study in rats was designed to evaluate the potential of a single intravenous bolus of an investigational BK channel antagonist in clinical development (ENA-001) to mitigate the acute respiratory depression induced by prior intravenous bolus infusion of an XFC to rats. The gene discussed is KCNMA1; the disease is Respiratory insufficiency due to muscle weakness.